Latest DEF 14A proxy statements

Virco Mfg. Corporation announces its 2026 Annual Meeting of Stockholders to be held on June 16, 2026, detailing proposals for director elections, executive compensation, and auditor ratification.

PagerDuty invites stockholders to its 2026 Annual Meeting on June 18, 2026, to elect directors, ratify auditor selection, and vote on executive compensation.

Wellgistics Health, Inc. is holding a special meeting on May 21, 2026, to vote on a name change to Vantix Health Inc., authorizing preferred stock, and amending its equity incentive plan.

STAAR Surgical Company has released its proxy statement for the 2026 Annual Meeting of Shareholders, detailing director nominations, equity plan amendments, auditor ratification, and executive compensation.

Veeva Systems Inc. has issued its proxy statement detailing the agenda for its 2026 Annual Meeting of Shareholders, including the election of directors and ratification of its independent auditor.

Imunon, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 16, 2026, to elect directors, ratify auditors, and vote on executive compensation and stock incentive plan amendments.

Idaho Strategic Resources, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting agenda, including director elections and auditor ratification.

GitLab Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and the ratification of its independent auditor.

Everpure reports strong fiscal 2026 performance with $3.7B in revenue and outlines executive compensation tied to growth.

Sprinklr, Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification.

WidePoint Corporation schedules its 2026 Annual Meeting of Stockholders for June 19, 2026, to address director elections and auditor ratification.

PAVmed Inc. has issued its 2026 proxy statement detailing proposals for director elections, an ESPP amendment, and auditor ratification.

Bakkt's 2026 proxy statement outlines the company's strategic pivot, board restructuring, and the acquisition of Distributed Technologies Research (DTR).

CION Investment Corporation has scheduled its 2026 Annual Meeting of Shareholders for June 25, 2026, to elect two directors and ratify its independent auditor.

Syndax Pharmaceuticals announces its 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026.

DXP Enterprises, Inc. announces its 2026 Annual Meeting of Shareholders to address director elections, executive compensation, and auditor ratification, following a strong fiscal year 2025 performance.

Ocular Therapeutix, Inc. filed its 2026 proxy statement detailing executive compensation, director elections, and a proposal to increase the 2021 Stock Incentive Plan by 10 million shares.

Comstock Holding Companies, Inc. announces its 2026 Annual Meeting of Stockholders to be held on June 17, 2026.

United Parks & Resorts Inc. releases its 2026 proxy statement detailing director elections, executive compensation, and governance updates following a challenging 2025 fiscal year.

Kaltura, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 24, 2026.

XPEL, Inc. announces its 2026 Annual Meeting of Stockholders to be held on June 10, 2026, covering director elections, auditor ratification, and executive compensation.

Contango Silver & Gold Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 18, 2026.

Kiora Pharmaceuticals announces its 2026 Annual Meeting of Stockholders to be held on June 10, 2026, featuring proposals for director elections, executive compensation, and an equity plan amendment.

Alto Ingredients, Inc. reported a significant financial turnaround in 2025, driven by strategic initiatives, increased net income, and strong Adjusted EBITDA growth.

Grindr Inc. announces its 2026 Annual Meeting, seeking shareholder approval for an equity incentive plan amendment and the election of eight director nominees.

AtlasClear Holdings, Inc. has issued its 2026 proxy statement seeking shareholder approval for director elections, an equity incentive plan amendment, and auditor ratification.

Adagio Medical Holdings, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 16, 2026.

Optimum Communications, Inc. has released its 2026 proxy statement detailing director elections, executive compensation, and governance practices.

Lucid Diagnostics Inc. has filed its proxy statement for the 2026 Annual Meeting, seeking approval for a capital increase and director elections.

TELA Bio, Inc. announces its 2026 Annual Meeting of Stockholders, featuring a significant board refreshment and a proposal to increase equity incentive plan shares.